Tedral

Tedral was a combination medication used primarily in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It was composed of three active ingredients: theophylline, ephedrine, and phenobarbital. This combination was designed to provide bronchodilation, stimulation, and sedation effects to manage respiratory conditions.

Composition

Theophylline

Theophylline structure

Theophylline is a methylxanthine drug that acts as a bronchodilator. It works by relaxing the smooth muscles of the bronchi, thereby easing breathing in patients with obstructive airway diseases. Theophylline also has mild anti-inflammatory effects and can improve the contractility of the diaphragm, which is beneficial in respiratory conditions.

Ephedrine

Ephedrine structure

Ephedrine is a sympathomimetic amine that acts as a bronchodilator and decongestant. It stimulates the adrenergic receptors in the body, leading to the relaxation of bronchial muscles and increased airflow. Ephedrine also has stimulant effects, which can help counteract the sedative effects of phenobarbital in the Tedral formulation.

Phenobarbital

Phenobarbital structure

Phenobarbital is a barbiturate that provides sedative and anticonvulsant effects. In the context of Tedral, phenobarbital was included to mitigate the potential overstimulation caused by ephedrine and to provide a calming effect, which can be beneficial in managing anxiety associated with asthma attacks.

Mechanism of Action

Tedral's effectiveness in treating asthma and COPD was due to the combined actions of its components. Theophylline and ephedrine both contributed to bronchodilation, improving airflow and reducing respiratory distress. Phenobarbital helped to balance the stimulating effects of ephedrine, providing a more controlled and manageable treatment experience for patients.

Clinical Use

Tedral was prescribed for the management of asthma and COPD symptoms, particularly in cases where other treatments were not sufficient. It was used to prevent and relieve bronchospasm, reduce wheezing, and improve overall respiratory function.

Asthma attack illustration

Discontinuation

Tedral is no longer widely used due to the development of more effective and safer medications for asthma and COPD. Modern treatments focus on inhaled corticosteroids, long-acting beta agonists, and other targeted therapies that offer better control with fewer side effects.

Related Pages

• Asthma
• Chronic obstructive pulmonary disease
• Bronchodilator
• Methylxanthine
• Sympathomimetic drug